2019

CBD News: Statement by Ms. Elizabeth Maruma Mrema, Acting Executive Secretary, Convention on Biological Diversity, on the occasion of the meeting of the Ad Hoc Technical Expert Group on Invasive Alien Species, Montreal, 2-4 December 2019




2019

CBD Notification SCBD/OES/DC/KM/88539 (2019-108): Submission of views on possible targets, indicators and baselines for the post-2020 global biodiversity framework and peer review of a document on indicators




2019

CBD Notification SCBD/IMS/JMF/NS/ET/CP/88538 (2019-109): Date extension: Thematic Consultation on Transparent Implementation, Monitoring, Reporting and Review Mechanism, 20-22 February 2020 - Kunming, China and Thematic Consultation on Capacity Building a




2019

CBD Notification SCBD/CPU/DC/KG/PD/PS/88522 (2019-110): Review of post-2020 Implementation Plan and Capacity-building Action Plan (Cartagena Protocol on Biosafety)




2019

CBD News: Statement by Elizabeth Maruma Mrema, Acting Executive Secretary, Convention on Biological Diversity, on the occasion of World Soil Day 2019




2019

CBD Notification SCBD/SSSF/AS/SBG/JA/JMQ/88545 (2019-113): Submission of Information on Experiences in the Implementation of Marine Spatial Planning




2019

CBD Notification SCBD/IMS/JMF/MC/86437 (2019-111): Reminder: Sixth National Reports




2019

CBD Notification SCBD/IMS/JMF/ET/AR/DM/88533 (2019-112): Launch of the Bioland Tool for National Clearing-House Mechanism websites




2019

CBD Notification SCBD/SSSF/AS/ML/GD/88414 (2019-114): Tracking Economic Instruments and Finance for Biodiversity: Invitation to contribute data on positive incentives relevant to Aichi Biodiversity Target 3 to the OECD PINE database




2019

CBD Notification SCBD/SSSF/AS/SBG/ESE/88552 (2019-116): Request to Identify and Submit Data on Other Effective Area-Based Conservation Measures




2019

CBD Notification SCBD/IMS/JMF/NVW/86292 (2019-117): Follow-up invitation to participate in and/or contribute to the piloting and further development of a methodology for the voluntary peer review of national biodiversity strategies and action plans




2019

CBD News: Statement by Ms. Elizabeth Maruma Mrema, Acting Executive Secretary, Convention on Biological Diversity, at the fifty-seventh meeting of the Council of the Global Environment Facility, Wednesday, 18 December 2019, Washington D.C., United States




2019

CBD Notification SCBD/OES/DC/AC/88568 (2019-115): Submission of views on possible targets and indicators for the post-2020 global biodiversity framework related to the interlinkages and interdependencies between biodiversity and climate change




2019

CBD Notification SCBD/OES/DAIN/FV/UN/SN/FD/88542 (2019-118): Launching of the First Phase of the Newly Designed Website




2019

CBD Notification SCBD/CPU/DC/KG/MA/MW/88425 (2019-119): Composition of the Ad Hoc Technical Expert Group on Risk Assessment




2019

CBD News: Due to the ongoing situation following the outbreak of the novel coronavirus 2019, the Secretariat of the Convention on Biological Diversity (CBD), in consultation with the Government of the People's Republic of China, the COP (Conference of




2019

Emerging Roles for the Nucleolus 2019 [Meeting Report]

IntroductionThe nucleolus is the central organelle within eukaryotic cells whose primary function is to generate ribosomes, the major protein producing machines within all cells. New roles for the nucleolus are continuously emerging as we explore its molecular intricacies. Despite the central and fundamental role of the nucleolus in cell biology, there has previously been no single official meeting that enables the gathering of scientists whose research converges on the nucleolus. As a result, the community of researchers who study this organelle risks fragmentation across disciplines. The Emerging Roles for the Nucleolus Symposium, which has now taken place twice on a biennial basis, first in 2017 (1) and again in 2019, therefore, represents the first of its kind. The overarching goals of this symposium are (a) to convene researchers who study the nucleolus across model systems (yeast, nematodes, fruit flies, mouse, human cell lines) and biological perspectives (structural, biophysical, molecular, cellular, pathophysiology), (b) to share and disseminate the latest research breakthroughs in nucleolar biology, (c) to promote interaction, engagement, and collaboration centered on the nucleolus across disciplines, and (d) to provide trainees and early career investigators with an organelle-specific scientific community of support.The second Emerging Roles for the Nucleolus meeting was sponsored by the American Society for Biochemistry and Molecular Biology and was held at the Stowers Institute for Medical Research in Kansas City, MO, from October 24 to October 27, 2019. It was organized by Jennifer Gerton (Stowers Institute), Francesca Duncan (Northwestern University Feinberg School of Medicine), and Craig Pikaard...




2019

Life Planning Education Conference 2019 held today




2019

HKEAA submits 2019 Territory-wide System Assessment Report




2019

Speech by SED at opening ceremony of Learning and Teaching Expo 2019




2019

EDB announces arrangements for provision of Student Grant in 2019/20 school year




2019

Meet the Most Disruptive MBA Startups of 2019 Poets and Quants – 10/28/2019

Monday, October 28, 2019 - 12:15




2019

Responsible Business 2019

Conference

Priorities, practices and principles in a digital age

28 February 2019 - 9:30am to 5:00pm

Chatham House, London

Overview

Agenda

Speakers

Pricing and booking information

Sponsors

Media partners and supporting organizations

Venue and accommodation

Press registration

Contact us

Ever-increasing consumer, investor and employee awareness continues to drive the business case for responsible behaviour, and recent events have highlighted the growing need for corporate accountability and transparency from C-suite behaviour to global supply chain management. But what exactly are these expectations across different sectors, as the acceleration of the digital age continues to present new risks, opportunities and concerns? How can the right behaviours be encouraged? 

Furthermore, ongoing political transitions and regulatory stances over the last two years have shone a light on companies’ potential and realized impact on society. With trust in political institutions low, many are calling upon businesses not only to reflect their values but to actively bridge the governance gap on issues such as equality, sustainability and human rights, in their own business operations and beyond.  But what role should business be adopting, and what are the consequences of this trend? What are the perceived trade-offs? 

The past year has seen examples of technology leaders being held to account for the mishandling of data, global corporations taking a proactive stance on contentious political issues and executive behaviour directly impacting share price. It is critical that policy-makers and business leaders re-evaluate their priorities, practices and principles as technology and politics continue to reshape the landscape. 

The third annual Chatham House Responsible Business conference will explore key questions, including:

  • Who will lead the corporate responsibility agenda? What is driving responsible behaviour? 
  • To what extent has there been a policy retreat in this space? What has been the response to this, and what does it mean for different roles and responsibilities? 
  • What are the new priorities for responsible business in a digital age? How have recent events demonstrated a shift in expectations? 
  • How can policy-makers and companies foster the integration of human rights across global supply chains, international trade and regional business operations?
  • What is the role of corporate governance and leadership in setting standards and promoting responsible business? Is this a new era of corporate activism? 

The Chatham House Rule
To enable as open a debate as possible, this conference will be held under the Chatham House Rule.

Twitter
@CH_Events
#CHBusiness

Thursday 28 February
0920

Welcome and chair's opening remarks
Dr Robin Niblett, Director, Chatham House

Keynote address
Simon Thompson, Chairman, Rio Tinto

Questions and discussion

Session One | Leaders and Drivers
1000-1115

This opening session will examine the status of corporate leadership in responsible business, evolving policy environments and stakeholder expectations, and how they continue to shape roles and responsibilities. 

  • How are expectations for responsible business evolving? Where has this been most apparent in the past 18 months, and what is driving these shifts? 
  • Do policy and regulation continue to be effective at encouraging responsible business behaviour? Where is regulation most effective in this space? 
  • Given current political sentiments and levels of trust, what role should business play in creating a sustainable economy and a more equal society? What are the implications of this?  
  • What can business leaders learn from existing examples of corporate activism? 
  • Does a trade-off exist between responsible practices and economic competitiveness, or do commercial drivers incentivize better behaviours? How does this differ across different markets and regions?

Chair
Tamzin Booth, European Business Editor, The Economist

Speakers
Helena Morrissey, Head of Personal Investing, Legal & General Investment Management, and Founder of the 30% Club
Ioannis Ioannou, Associate Professor of Strategy and Entrepreneurship, London Business School
Phil Bloomer, Executive Director, Business & Human Rights Resource Centre​
Sue Garrard, EVP Sustainable Business and Communications, Unilever (2014-18)

Questions and discussion

1115-1145 Refreshments

Session Two | Practices and Transparency
1145-1300

This session will address regulatory frameworks and economic incentives governing responsible business conduct, as well as human rights and business operations across global supply chains. 

  • How prominent are business and human rights issues on national policy agendas? To what extent has this influenced business behaviours across different sectors and regions? 
  • What progress has been made with regards to the UN Guiding Principles for Business and Human Rights? What has most effectively driven their integration? 
  • To what extent can public opinion and public awareness help narrow the governance gap? How can investors actively promote and enforce better governance practices? 
  • Does transparency necessarily lead to accountability, and in turn increase consumer and investor trust? What are the implications of this? 
  • How can due diligence and reporting be made more efficient to enhance accountability as well as transparency across supply chains and investments? Can digital solutions be employed to achieve social and environmental best practice?

Chair
Bennett Freeman, Deputy Assistant Secretary for Democracy, Human Rights and Labor, US Department of State (1999–2001)

Speakers
Gillian Caldwell, CEO, Global Witness
Madelaine Tuininga, Head of Unit, DG Trade, European Commission
Sharan Burrow, General Secretary, International Trade Union Confederation 
Guus Houttuin, Trade Adviser, European External Action Service, and Chair, the OECD Multi-stakeholder Steering Group 

Questions and discussion

1300-1400 Lunch

Session Three | Responsibility in the Digital Age
1400-1515

This session will examine the risks and opportunities presented by digitization and other technological developments for responsible business practices. 

  • What have events over the past year indicated regarding stakeholder concerns accompanying specific technologies and business practices? How have different sectors and companies responded? 
  • What are the responsible business issues that accompany the transition to a digital-first society? What can be learned from the challenges of regulating tech titans?
  • How can businesses ensure data privacy and help customers with digital access to maintain trust and maximize benefits from digital transformation? 
  • To what extent is the proliferation of information through technology already enhancing corporate accountability and transparency? What are the risks here? 

Chair
John Thornhill, Innovation Editor, Financial Times

Speakers
Nuala O’Connor, President and CEO of the Center for Democracy and Technology
Simon McDougall, Executive Director, Technology Policy and Innovation, Information Commissioner’s Office​
Rebecca MacKinnon, Director, Ranking Digital Rights, New America
Sarah Drinkwater, Director, Tech and Society Solutions Lab, Omidyar Network

Questions and discussion

1515-1545 Afternoon refreshments

Session Four | Governance
1545-1700

This closing session will explore the role of corporate governance in setting standards and leading responsible business practices, including diversity and inclusion as well as C-suite accountability and transparency. 

  • How are businesses responding to expectations of good corporate governance and leadership in the digital age? Are businesses equipped to maintain high standards of accountability and transparency in the era of open data and social media?
  • Do business leaders have a responsibility to embody as well as promote high standards of responsible business and ethical leadership? What lessons can be learnt from corporate governance failings? 
  • What role should business leaders play in the broader political environment? Is corporate activism part of responsible governance, and what are the risks?
  • What are the best strategies to empower diversity and foster inclusion in a rapidly changing global economy? Should diversity and inclusion begin in the boardroom?

Chair
Aris Vrettos, Director of Open Programmes and International Markets, Cambridge Institute for Sustainability Leadership

Speakers
Catherine Howarth, CEO, ShareAction 
Jane Ellis, Director, GoodCorporation
Mo Ibrahim, Founder, Mo Ibrahim Foundation 
Alison Cottrell, CEO, Banking Standards Board

Questions and discussion

1700 Close of conference and drinks reception 

© The Royal Institute of International Affairs 2019

Keynote Speaker

Speakers

Phil Bloomer

Executive Director, Business & Human Rights Resource Centre

Tamzin Booth

Business Editor, The Economist

Sharan Burrow

General Secretary, International Trade Union Confederation

Gillian Caldwell

CEO, Global Witness

Alison Cottrell

CEO, Banking Standards Board

Sarah Drinkwater

Director, Tech and Society Solutions Lab, Omidyar Network

Jane Ellis

Director, GoodCorporation

Bennett Freeman

Deputy Assistant Secretary for Democracy, Human Rights and Labor, United States (1999-2001)

Sue Garrard

EVP Sustainable Business and Communications, Unilever (2014-18)

Guus Houttuin

Trade Adviser, European External Action Service, and Chair, the OECD Multi-stakeholder Steering Group

Catherine Howarth

CEO, ShareAction

Mo Ibrahim

Founder, Mo Ibrahim Foundation

Ioannis Ioannou

Associate Professor of Strategy and Entrepreneurship, London Business School

Rebecca MacKinnon

Director, Ranking Digital Rights, New America

Simon McDougall

Executive Director, Technology Policy and Innovation, Information Commissioner's Office

Dame Helena Morrissey

Head of Personal Investing, Legal & General Investment Management; Founder, 30% Club

Dr Robin Niblett CMG

Director, Chatham House

Nuala O'Connor

President and CEO, Center for Democracy & Technology

John Thornhill

Innovation Editor, Financial Times

Madelaine Tuininga

Head of Unit, DG Trade, European Commission

Aris Vrettos

Director of Open Programmes and International Markets, Cambridge Institute for Sustainability Leadership

Ways to book:

  1. Online: Click here to complete the online registration form
  2. Phone: Call Boudicca Georgii Hellberg on +44 (0) 20 7314 2785
  3. Email/Post: Download a PDF registration form, complete and return to Boudicca Georgii Hellberg via email or post: Chatham House, 10 St. James Square, London, SW1Y 4LE

Check if your organization is a member of Chatham House here.

 RATE (+VAT):
Partners and major corporate members 
All organizations£595
Standard corporate members 
Commercial organizations£1,180
Government departments/agencies/intergovernmental organizations£700
NGOs/academic institutions/associations (including not for profits and registered charities)£460
Non-members 
Commercial organizations£1,295
Government departments/agencies/intergovernmental organizations£750
NGOs/academic insitutions/associations (including not for profits and registered charities)£510
 
 

Your delegate pass includes:

  • Documentation
  • Lunch and refreshments

Travel and accommodation are not included.

If you are interested in becoming a sponsor for this event, please contact Olivia Lewis on +44 (0)20 7957 5732

If you are interested in partnering with Chatham House on this event, please contact Ayesha Arif on +44 (0)20 7957 5753

Chatham House
10 St James's Square
London
SW1Y 4LE
UK
conferences@chathamhouse.org

Telephone: +44 (0)20 7957 5643
Fax: +44 (0)20 7957 5710

If you wish to book the venue for your own event please phone +44 (0)20 7314 2764

Directions
The nearest tube station is Piccadilly Circus which is on the Piccadilly and the Bakerloo Underground lines. From Piccadilly follow Regent Street southwards towards Pall Mall and take the first road on the right called Jermyn Street. Duke of York Street is the second road on the left and leads to St James's Square. Chatham House is immediately on your right.

Map

Accommodation
Although we cannot book accommodation for delegates, we have arranged a reduced rate at some nearby hotels, where you can book your own accommodation. Please inform the hotel that you will be attending a conference at Chatham House (The Royal Institute of International Affairs) to qualify for the Institute's reduced rate.

Please note all rates are subject to availability.

Flemings Mayfair
13 Half Moon Street
Mayfair
London - W1J 7BH

Tel: + 44 (0)20 7499 2964
Fax: + 44 (0)20 7499 1817
reservations@flemings.co.uk

Classic Double without breakfast: £195 +VAT

The Cavendish London
81 Jermyn Street
London - SW1U 6JF

Tel: + 44 (0)20 7930 2111
Fax: + 44 (0)20 7839 2125
enquiry.cavendish@the-ascott.com 

Classic Room without breakfast: £195 +VAT

Book The Cavendish online

The Stafford London 
St James's Place
London - SW1A 1NJ

Tel: 020 7493 0111
Fax: 020 7493 7121
​reservations@thestaffordlondon.com

Classic Queen without breakfast: £247 +VAT
Quote Chatham House

This conference will be held under the Chatham House Rule. Information for journalists.

Press can request a press pass.

For enquiries relating to the conference agenda or sponsorship please call Olivia Lewis on +44 (0) 20 7957 5732

For registration enquiries please call Boudicca Georgii Hellberg on +44 (0) 20 7314 2785

For general enquiries please email conferences@chathamhouse.org 

Department/project




2019

Inclusive Growth and Job Creation in Africa: The Outlook for 2019 and Beyond

Invitation Only Research Event

30 September 2019 - 1:30pm to 2:30pm

Chatham House | 10 St James's Square | London | SW1Y 4LE

Event participants

Abebe Aemro Selassie, Director, African Department, International Monetary Fund
Chair: Elizabeth Donnelly, Deputy Head and Research Fellow, Africa Programme, Chatham House

The IMF projects real GDP growth of 3.3 per cent in 2019 for sub-Saharan Africa but there is a mixed picture across the continent with growth in Mauritania, Senegal, Ethiopia and Rwanda outstripping projected growth rates for South Africa and Nigeria, for example, while a handful of economies seek to emerge from crisis. Yet, as is increasingly well documented, even strong growth has not delivered lasting socio-economic transformation in many contexts. And that most pressing of needs – job creation including to accommodate, in the next 15 years, an increase in the working age population greater than that in the rest of the world combined – remains a pressing concern for governments and societies. With populations continuing to grow at faster rates than economic growth, and a significant proportion of jobs outside agriculture being in the informal sector, investment in formal labour markets is crucial to creating inclusive economic growth.
 
At this event, the International Monetary Fund’s Africa Director, Abebe Aemro Selassie will discuss the outlook for sub-Saharan African economies in 2019 and progress towards achieving inclusive economic growth to accommodate future demographic change.
 
Attendance at this event is by invitation only. 

Yusuf Hassan

Parliamentary and Media Outreach Assistant, Africa Programme
+44 (0) 20 7314 3645




2019

UK General Election 2019: What the Political Party Manifestos Imply for Future UK Trade

Research Event

4 December 2019 - 12:30pm to 1:30pm

Chatham House | 10 St James's Square | London | SW1Y 4LE

Event participants

Michael Gasiorek, Professor of Economics, University of Sussex; Director, Interanalysis; Fellow, UK Trade Policy Observatory, University of Sussex
Julia Magntorn Garrett, Research Officer, UK Trade Policy Observatory, University of Sussex
Prof Jim Rollo, Deputy Director, UK Trade Policy Observatory, University of Sussex; Associate Fellow, Global Economy and Finance Department, Chatham House
Nicolo Tamberi, Research Officer in the Economics of Brexit, University of Sussex
L. Alan Winters, Professor of Economics, Director, UK Trade Policy Observatory, University of Sussex

The upcoming UK general election is arguably a 'Brexit election', and as such, whoever wins the election will have little time to get their strategy for Brexit up and running to meet the new Brexit deadline of 31 January 2020. But what are the political parties’ policies for the UK's future trade? This event will present and discuss what the five main parties’ manifestos imply for future UK trade. Each manifesto will be presented and analysed by a fellow of the UK Trade Policy Observatory (UKTPO) and will be followed by a Q&A session. 

Michela Gariboldi

Research Assistant, Global Economy and Finance Programme
02073143692




2019

In Memoriam: Lina M. Obeid (1957-2019)

Ashley J. Snider
Apr 1, 2020; 61:466-467
Tribute




2019

The multilevel identity politics of the 2019 Eurovision Song Contest

7 May 2020 , Volume 96, Number 3

Galia Press-Barnathan and Naama Lutz

This article uses the 2019 Eurovision Song Contest (ESC) that took place in Tel Aviv to explore how cultural mega-events serve both as political arenas and as tools for identity construction, negotiation and contestation. These processes of identity politics are all conducted across national–subnational–international–transnational levels. The hosting of mega-events fleshes out these multiple processes in a very strong manner. We first discuss the politics of hosting mega-events in general. We then examine the identity politics associated more specifically with the Eurovision Song Contest, before examining in depth the complex forms of identity politics emerging around the competition following the 2018 Israeli victory. We suggest that it is important to study together the multiple processes—domestic, international and transnational—of identity politics that take place around the competition, as they interact with each other. Consequently, we follow the various stakeholders involved at these different levels and their interactions. We examine the internal identity negotiation process in Israel surrounding the event, the critical actors debating how to use the stage to challenge the liberal, western, ‘normal’ identity Israel hoped to project in the contest and how other stakeholders (participating states, national broadcasting agencies, participating artists) reacted to them, and finally we examine the behaviour of the institution in charge, the European Broadcasting Union, and national governments. We contribute to the study of mega-events as fields of contestation, to the understanding of the complex, multilevel nature of national identity construction, negotiation and contestation in the current era, and more broadly to the role that popular culture plays in this context.




2019

In Memoriam: Lina M. Obeid (1957-2019) [Tribute]




2019

Rays' 2019 mantra: Prepare to win from within

Over the past couple seasons, the Rays have preached patience as the organization provided time for the top prospects to make it up to the Majors. Now, the focus has been primarily in remaining flexible and keeping positions open for the young talent arriving from the Minors.




2019

Kiermaier eyeing 'huge rebound year' in 2019

Kevin Kiermaier has always played with a chip on his shoulder, but he admits that there's some extra motivation heading into Spring Training after a frustrating 2018 season.




2019

Sternberg optimistic about 2019, Rays' stadium

Rays principal owner Stuart Sternberg won't make any big prediction entering the 2019 season, but he still expressed a lot of enthusiasm during Tuesday's media session.




2019

Erratum. Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. Diabetes 2019;68:441--456




2019

Diabetes Core Update – July 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Prognostic Significance of Unrecognized MI in Patients with Diabetes
  2. Driving and Glucose Variability
  3. Fournier Gangrene Associated with SGLT-2 Inhibitors
  4. Faster Acting Insulin Aspart vs. Insulin Aspart
  5. Sleep and Glycemia
  6. Flash Glucose Monitoring and Effect on Glycemic Control

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – August 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Dapagliflozin Plus Saxagliptin Add-on Therapy Compared with Insulin
  2. Dulaglutide and Cardiovascular Outcomes in Type 2 Diabetes (REWIND)
  3. Mediterranean Diet and the Need for Glucose- Lowering Medications
  4. Oral Semaglutide versus Subcutaneous Liraglutide and Placebo
  5. Vitamin E and Pioglitazone for Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes
  6. Durability of Insulin Degludec plus Liraglutide versus Insulin Glargine U100

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – September 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Oral Semaglutide Monotherapy in Type 2 Diabetes
  2. Lifestyle Counseling and Long-term Clinical Outcomes
  3. Economic Burden of Diabetes in the United States
  4. Microvascular Disease and Heart Failure with Preserved Ejection Fraction
  5. Optimal Blood Pressure Target for Patients with Type 1 Diabetes
  6. Lack of Durable Improvements in Beta-Cell Function after Medication Withdrawal in Prediabetes

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – October 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Nasal Glucagon
  2. Incidence of type 2 diabetes in people with a history of hospitalization for major mental illness
  3. Achievement of Target A1C <7.0% after treatment with basal insulin in Randomized Controlled Trials and Clinical Practice
  4. Metformin effect on Coronary endothelial Dysfunction in prediabetic patients with stable angina
  5. Change in cardiovascular health risk and the development of type 2 diabetes and impaired fasting glucose
  6. Association between diabetes HbA1c, glycaemia and development of frailty in the elderly

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – November 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Glycemia Reduction Approaches in Diabetes (GRADE) Trial
  2. The Effect of Disasters on Patients with Diabetes
  3. Fixed Ratio GLP-1/Basal Insulin in Patients Uncontrolled on GLP-1
  4. Mechanisms of CV Protection for SGLT-2 Inhibitors
  5. Oral Semaglutide and Cardiovascular Outcomes
  6. Trends in Pancreatitis and Pancreatic Cancer in patients started on DPP-4 Inhibitors

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – December 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Combination Basal Insulin/GLP-1 RA vs Basal Bolus for Persons with Very Elevated A1c
  2. Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and the Risk of Type 2 Diabetes
  3. Oral Semaglutide vs. Placebo added to Insulin : The PIONEER 8 Trial
  4. Residual Hypertriglyceridemia and Estimated Atherosclerotic CV Risk by Stain Use in U.S. Adults with Diabetes
  5. A1c Variability and the Risk of Poor Outcomes in People with Type 2 Diabetes
  6. Oral Semaglutide vs. Empagliflozin in Persons with Type 2 Diabetes Uncontrolled on Metformin

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – January 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Linagliptin in Older adults on Insulin
  2. Lactic Acidosis from Metformin – FDA analysis
  3. Glucagon Receptor Antagonist RV-1502 – Efficacy and Safety
  4. Early Identification of MODY
  5. SGLT-2 Inhibitors and the Development of Mycotic Infections and UTIs
  6. SFLT-2 Inhibitors in Patients with Type 1 Diabetes and the Rate of Diabetic Ketoacidosis

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – February 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Efficacy and safety of dapagliflozin in the elderly Lactic Acidosis from Metformin – FDA analysis
  2. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the United States
  3. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
  4. Transitioning to Fixed-Ratio Combination Therapy: Practical Advice
  5. General practitioner advice associated with greater physical activity in adults with type 2 diabetes
  6. Empagliflozin Effectively Lowers Liver Fat Content

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – March 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This month we review articles on:

  1. Association of body mass index, fitness, and mortality in patients with diabetes
  2. Cognitive deficits and traditional diabetic complications in the severely obese
  3. Late Relapse of Diabetes after Bariatric Surgery
  4. Hypoglycemia in Type 1 Diabetes and Subsequent Cognitive Deficits
  5. Nutrient Induced Beta Cell Stress
  6. Topical Oxygen Therapy in the Treatment of Diabetic Foot Ulcers

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health

 




2019

Diabetes Core Update – COVID-19 UPDATE: March 2019

This is a special issue focusing on Covid-19 and Diabetes:

  1. Characteristics of and Important Lessons From
    the Coronavirus Disease 2019 (COVID-19) Outbreak in China
  2. Clinical course and risk factors for mortality
  3. Diabetes and Hypertension: Are ACE’s, ARBs and NSAIDs OK to Use?

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health




2019

Diabetes Core Update – April 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

  1. Normalization of functional beta cell capacity after weight loss in type 2 diabetes
  2. Screening for glucose intolerance and diabetes in patients with coronary artery disease
  3. Trends Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018
  4. Impact of a Telephone Intervention to Improve Diabetes Control on Healthcare Utilization and Cost for Adults in South Bronx, New York –
  5. Efficacy and Safety of Dapagliflozin Plus Saxagliptin Versus Insulin Glargine Over 52 Weeks as Add‐on to Metformin With or Without Sulfonylurea in Patients With Type 2 Diabetes
  6. The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health




2019

Diabetes Core Update: Covid-19 - Planning Sick Days April 2019

This special issue focuses on Diabetes, Covid-19 and managing patient’s diabetes when they are sick.

Recorded April 1, 2020.

This podcast will cover:

  1. How do we help our patients with diabetes stay safe
  2. Helping patient negotiate safety issues in the workplace
  3. Safety Issues when people do not come in for care
  4. Managing SGLT-2 inhibitors during the pandemic
  5. Home detection and care of DKA
  6. Renewing Medications
  7. Telemedicine Visits

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

Presented by:

Louis Philipson, MD, PhD, ADA Past President, Medicine & Science, University of Chicago

Anne Peters, MD, Diabetologist, University of Southern California




2019

Diabetes Core Update: Covid-19 – Inpatient Management of Persons with Diabetes April 2019

This special issue focuses on Diabetes, Covid-19 and Inpatient Management.

Recorded April 3, 2020.

This podcast will cover:

  1. Risk with Diabetes of Covid-19 and Complications of Covid-19
  2. Management of Hyperglycemia during Covid-19 Infection
  3. Sub-cutaneous Insulin for DKA
  4. CGM in the Hospital Setting
  5. Diabetes Education in the Hospital During Covid-19

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

Presented by:

Irl Hirsch, MD, Professor of Medicine, University of Washington, Seattle

Guillermo E. Umpierrez, MD, CDE, Professor of Medicine, Emory University, Atlanta Georgia




2019

Diabetes Core Update: Covid-19 – Deep Dive into Medication Management April 2019

This special issue focuses on Diabetes, Covid-19 and Inpatient Management.

Recorded April 14, 2020.

This podcast will cover:

  1. Inpatient Medication Management for Persons Admitted with Diabetes
  2. Outpatient Medication Management for Persons with Diabetes
    1. Hypoglycemic Medication Management
    2. ACE and ARBs
    3. NSAIDs

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Dr. Joshua Neumiller, Vice Chair & Allen I. White Distinguished Associate Professor of Pharmacotherapy at Washington State University




2019

Diabetes Core Update: Covid-19 and Diabetes – Considerations for Health Care Professionals - April 2019

Diabetes Core Update: Covid-19 and Diabetes – Considerations for Health Care Professionals - April 2019

This special issue is an audio version of the American Diabetes Associations Covid-19 leadership team discussing a range of issues on Covid-19 and Diabetes.

Recorded March 31, 2020.

Topics include:

  1. Access to medications
  2. Effect on Diabetes Self-management
  3. Can Patients take their own Supplies if they are an inpatient in the hospital – particularly insulin pumps and CGM
  4. Considerations for Specific Hypoglycemic Medications during Inpatient Hospitalization
  5. Differences in Management for Persons with Type 1 and Type 2 Diabetes
  6. SGLT-2 inhibitors and GLP-1 Receptor Agonists use During Covid-19 Infection
  7. Diabetes and Cardiovascular Disease during Covid-19
  8. ACEs and ARBs
  9. Stress among Healthcare Professionals

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

Presented by:

Robert Eckel, MD
ADA President, Medicine & Science
University of Colorado

Mary de Groot, PhD
ADA President, Health Care & Education
Indiana University

Irl Hirsch, MD
University of Washington

Anne Peters, MD
University of Southern California    

Louis Philipson, MD, PhD
ADA Past President, Medicine & Science
University of Chicago

Neil Skolnik, MD
Abington Jefferson Health




2019

Diabetes Core Update: COVID-19 – Inpatient Management # 2 April 2019

This special issue focuses on Answering Questions about Inpatient Care During Covid 19, a follow-up discussion to the Townhall meeting discussing inpatient care. 

Recorded April 15, 2020.

This podcast will cover:

  1. Subcutaneous Insulin Infusions
  2. CGM use in the inpatient setting
  3. Insulin Infusion pumps in the inpatient setting
  4. Inpatient Glycemic Control - what are the recommendations?
  5. Oral Medications
  6. Hydroxychloroquine adverse effects in persons with diabetes

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

Presented by:

Robert Eckel, MD
ADA President, Medicine & Science

Irl Hirsch, MD
University of Washington

Mary Korytkowski, MD
University of Pittsburgh




2019

Diabetes Core Update: COVID-19 – Inpatient Townhall April 2019

This special issue focuses on Answering Questions about Inpatient Care During Covid 19, a follow-up discussion to the Townhall meeting discussing inpatient care. 

Recorded April 7, 2020.

This is a part of the American Diabetes Associations ongoing project providing resources for practicing clinicians on the care of Diabetes during the Covid-19 pandemic.  Todays discussion is an audio version of a webinar recorded on April 17th, 2020 where the panel answered questions submitted during and after the last webinar/townhall a week prior on inpatient management of patients with diabetes with Covid-19.

Presented by:

Shivani Agarwal, MD, MPH
Albert Einstein College of Medicine

Jennifer Clements, PharmD, FCCP, BCPS, CDE, BCACP
American Pharmacists Association

Robert Eckel, MD
ADA President, Medicine & Science

Irl Hirsch, MD
University of Washington

Melanie Mabrey, DNP 
Co-Chair - American Association of Nurse Practitioners - Endocrine Specialty Practice Group

Jane Jeffrie-Seley, DNP, BC-ADM, CDCES
Association of Diabetes Care and Education Specialists 




2019

Diabetes Core Update: COVID-19 – Telehealth and COVID-19 , April 2019

This special issue focuses on Telehealth and COVID-19.

Recorded March 31, 2020.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

Presented by:

Neil Skolnik, MD
Sidney Kimmel Medical College, Thomas Jefferson University

Eric Johnson, MD
University of North Dakota School of Medicine and Health Sciences